CompanyLPCNNasdaqSalt Lake City, X1 Lipocine Inc.
Lipocine develops oral drug candidates using proprietary delivery technology for postpartum depression, major depressive disorder, epilepsy, essential tremor, obesity, liver cirrhosis symptoms, and preterm birth prevention.
8-KNov 10Latest SEC filing Nov 10Latest story